Entrectinib in locally advanced / metastatic ROS1 and NTRK fusion-positive (NTRK plus ) non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001 Meeting Abstract


Authors: Springfeld, C.; de Braude, F.; Siena, S.; Barlesi, F.; Drilon, A.; Simmons, B.; Huang, X.; Pitcher, B.; Doebele, R. C.
Abstract Title: Entrectinib in locally advanced / metastatic ROS1 and NTRK fusion-positive (NTRK plus ) non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
Meeting Title: 34. Deutscher Krebskongress (DKK)
Journal Title: Oncology Research and Treatment
Volume: 43
Issue: Suppl. 1
Meeting Dates: 2020 Feb 19-22
Meeting Location: Berlin, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2020-02-01
Start Page: 235
Language: English
ACCESSION: WOS:000517158700583
PROVIDER: wos
DOI: 10.1159/000506491
Notes: "34th German Cancer Congress" -- Meeting Abstract: 948 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon